Multiple sclerosis trials in Denmark

In Denmark 19 Also abroad 506

19 of 19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Where
Esbjerg, Gistrup, Viborg
Age
18 years to 60 years
People
705 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00
Phase 3Taking people
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Where
Gistrup, Viborg
Age
18 years to 60 years
People
990 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00
Phase 3Taking people
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Where
Esbjerg, Glostrup
Age
18 years to 64 years
People
386 worldwide
Run by
Sanofi-Aventis Recherche & Developpement
See details and how to join2023-504358-36-00 · EU 2023-504358-36-00
Phase 3Taking people
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Where
Aarhus N, Glostrup
Age
40 years to 70 years
People
400 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06846281 · EU 2023-509275-17-00
Phase 3Taking people
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Where
Glostrup
Age
18 years to 64 years
People
125 worldwide
Run by
Amgen Inc.
See details and how to join2024-512914-16-00 · EU 2024-512914-16-00
No phaseTaking people
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
Where
Odense
Age
18 years to 80 years
People
60
Run by
Odense University Hospital
See details and how to joinNCT05380856
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Where
Aarhus N, Esbjerg, Glostrup Municipality, Odense C
Age
18 years to 65 years
People
1,275 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07225504
Phase 3Taking people
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Where
Esbjerg, Glostrup
Age
18 years to 60 years
People
160 worldwide
Run by
Sanofi
See details and how to joinNCT07325292 · EU 2026-525688-41-00
No phaseTaking people
At Home Use of Stimulation Suits for Managing MS Symptoms
Where
Ry
Age
18 years and over
People
70 worldwide
Run by
Daphne Kos
See details and how to joinNCT07202195
No phaseTaking people
Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
Where
Hvidovre
Age
18 years to 65 years
People
60
Run by
Danish Research Centre for Magnetic Resonance
See details and how to joinNCT06569550
Phase 2Taking people
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Where
Gistrup
Age
18 years to 64 years
People
93 worldwide
Run by
Zenas Biopharma (USA) LLC
See details and how to join2024-512707-40-00 · EU 2024-512707-40-00
Phase 3Taking people
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Where
Aarhus N, Esbjerg, Glostrup, Odense C
Age
18 years and over
People
677 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00
Phase 2Taking people
Psilocybin Therapy for Psychological Distress in Palliative Patients
Where
Copenhagen Nv
Age
18 years and over
People
108 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01
No phaseTaking people
Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis
Where
Glostrup Municipality
Age
18 years to 65 years
People
220
Run by
Glostrup University Hospital, Copenhagen
See details and how to joinNCT07318129
No phaseTaking people
EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis
Where
Aarhus
Age
18 years and over
People
116
Run by
University of Aarhus
See details and how to joinNCT07342777
No phaseTaking people
Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis
Where
Copenhagen, Roskilde
Age
18 years to 70 years
People
20
Run by
Zealand University Hospital
See details and how to joinNCT07304375
Phase 2Not yet taking people in Denmark
Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
Where
Haslev, Ry
Age
18 years and over
People
94 worldwide
Run by
Danish Multiple Sclerosis Hospitals
See details and how to joinNCT07310914
Phase 2Taking people
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Where
Haslev, Ry
Age
18 years and over
People
64
Run by
Lars Hvid
See details and how to joinNCT06956326
No phaseTaking people
Resistance Training and Corticospinal Excitability in Multiple Sclerosis
Where
Aarhus, Copenhagen
Age
18 years and over
People
54
Run by
University of Aarhus
See details and how to joinNCT06374108